Literature DB >> 29481373

Anticholinergic Medications and Cognitive Function in Late Midlife.

Martin M Limback-Stokin1, Janina Krell-Roesch1, Kimberly Roesler1, Allison Hansen1, Cynthia M Stonnington2, M'hamed Temkit3, Richard J Caselli4, Yonas E Geda1,2,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29481373      PMCID： PMC6107383          DOI： 10.1097/WAD.0000000000000251

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN： 0893-0341            Impact factor:   2.703


× No keyword cloud information.
  8 in total

1.  Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI.

Authors:  J E Hixson; D T Vernier
Journal:  J Lipid Res       Date:  1990-03       Impact factor: 5.922

2.  Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study.

Authors:  Marie L Ancelin; Sylvaine Artero; Florence Portet; Anne-Marie Dupuy; Jacques Touchon; Karen Ritchie
Journal:  BMJ       Date:  2006-02-01

3.  Longitudinal modeling of age-related memory decline and the APOE epsilon4 effect.

Authors:  Richard J Caselli; Amylou C Dueck; David Osborne; Marwan N Sabbagh; Donald J Connor; Geoffrey L Ahern; Leslie C Baxter; Steven Z Rapcsak; Jiong Shi; Bryan K Woodruff; Dona E C Locke; Charlene Hoffman Snyder; Gene E Alexander; Rosa Rademakers; Eric M Reiman
Journal:  N Engl J Med       Date:  2009-07-16       Impact factor: 91.245

4.  Association between anticholinergic drugs and apolipoprotein E epsilon4 allele and poorer cognitive function in older cardiovascular patients: a cross-sectional study.

Authors:  Juho Uusvaara; Kaisu H Pitkala; Pentti J Tienari; Hannu Kautiainen; Reijo S Tilvis; Timo E Strandberg
Journal:  J Am Geriatr Soc       Date:  2009-03       Impact factor: 5.562

5.  Cumulative anticholinergic exposure is associated with poor memory and executive function in older men.

Authors:  Ling Han; Joseph V Agostini; Heather G Allore
Journal:  J Am Geriatr Soc       Date:  2008-12       Impact factor: 5.562

6.  Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population: the 3-city study.

Authors:  Isabelle Carrière; Annie Fourrier-Reglat; Jean-François Dartigues; Olivier Rouaud; Florence Pasquier; Karen Ritchie; Marie-Laure Ancelin
Journal:  Arch Intern Med       Date:  2009-07-27

7.  Disruption of cholinergic neurotransmission exacerbates Aβ-related cognitive impairment in preclinical Alzheimer's disease.

Authors:  Yen Ying Lim; Paul Maruff; Rachel Schindler; Brian R Ott; Stephen Salloway; Don C Yoo; Richard B Noto; Cláudia Y Santos; Peter J Snyder
Journal:  Neurobiol Aging       Date:  2015-07-10       Impact factor: 4.673

8.  Modelling dementia: effects of scopolamine on memory and attention.

Authors:  P Broks; G C Preston; M Traub; P Poppleton; C Ward; S M Stahl
Journal:  Neuropsychologia       Date:  1988       Impact factor: 3.139
  8 in total
  3 in total

1.  The cognitive effects of anticholinergic drugs on apolipoprotein ε4 carriers and noncarriers in the Wisconsin Registry for Alzheimer's Prevention study.

Authors:  Brian G Collin; Dheeraj Raju; Steven Katsikas
Journal:  Neuropsychology       Date:  2021-02       Impact factor: 3.295

Review 2.  Beauty of the beast: anticholinergic tropane alkaloids in therapeutics.

Authors:  Kyu Hwan Shim; Min Ju Kang; Niti Sharma; Seong Soo A An
Journal:  Nat Prod Bioprospect       Date:  2022-09-16

Review 3.  Anticholinergic Drugs in Geriatric Psychopharmacology.

Authors:  Jorge López-Álvarez; Julia Sevilla-Llewellyn-Jones; Luis Agüera-Ortiz
Journal:  Front Neurosci       Date:  2019-12-06       Impact factor: 4.677
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.